Prevalence of SARS-CoV-2–Specific Antibodies, Japan, June 2020

We used 2 commercially available antibody tests to estimate seroprevalence of severe acute respiratory syndrome coronavirus 2 infection in Japan during June 2020. Of 7,950 samples, 8 were positive by both assays. Using 2 reliable antibody tests in conjunction is an effective method for estimating se...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshiyama, Takashi, Saito, Yasuki, Masuda, Kunitsugu, Nakanishi, Yoshiko, Kido, Yasutoshi, Uchimura, Kazuhiro, Mitarai, Satoshi, Suzuki, Tadaki, Nakagama, Yu, Kubota, Hiroshi, Satomi, Maki, Uchikoba, Sana, Ohnishi, Makoto, Wakita, Takaji, Kato, Seiya, Kato, Katsunobu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2021
Materias:
Dispatch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7853542/
https://www.ncbi.nlm.nih.gov/pubmed/33496235
http://dx.doi.org/10.3201/eid2702.204088

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7853542/
https://www.ncbi.nlm.nih.gov/pubmed/33496235
http://dx.doi.org/10.3201/eid2702.204088

Ejemplares similares